Clinical Pharmacist - Thrombosis & Hemostasis

Come join Hartford Healthcare and work where every moment matters! Hartford Hospital is hiring a Clinical Pharmacist for our Inpatient Pharmacy Department.

Looking to invest in the right candidate regardless of prior pharmacy experience.

Supportive environment to promote professional development and growth

Hartford Hospital doesn't just take great care of our patients; we take great care of our Clinical
Pharmacists too. We offer:

• Tuition Assistance up to $5,250.00 per year after six months of employment and up to 40% tuition discounts with partnering institutions for colleague AND dependents
• Employee assistance and wellness programs including a strong focus on promoting mental health
• Paid time off and health insurance packages
• Pharmacist Career Ladder to advance within the profession
• Pharmacy growth opportunities in areas such as leadership, informatics, clinical pharmacy, oncology and ambulatory care.
• Access to advanced resources and state of the art pharmacy software
• Opportunities for community involvement
• Free parking

Hartford Hospital is one of the largest and most respected teaching hospitals in New England. We are a Level 1 Trauma Center that provides cutting edge treatment to its patients. This is made possible by being home to the largest robotic surgery center in the Northeast and the Center for Education, Simulation and Innovation (CESI), one of the most-advanced medical simulation training centers in the world.

When hospitals cannot provide the advanced care, expertise and new treatment options for their patients require, they turn to us.

The Clinical Pharmacist ensures optimal drug therapy for patients in their clinical specialty area and provides educational activities to the pharmacy staff and other caregivers to insure that patients receive safe and cost effective drug therapy.

Reports to:

Pharmacy Manager.

• Serves as the health system subject matter expert for thrombosis, anticoagulation, hemostasis, and blood factor therapies.
• Provides strategic oversight for policies, procedures, protocols, and clinical guidelines related to:
  • Anticoagulants (warfarin, heparin, enoxaparin, DOACs)
  • Antiplatelet agents (cangrelor, ticagrelor, and others)
  • Reversal agents
  • Coagulation factor products
  • Massive hemorrhage management
• Leads the development, implementation, and maintenance of evidence-based practices for:
  • Anticoagulation management and reversal
  • Peri-procedural antithrombotic therapy
  • Bleeding emergencies
  • Factor replacement therapy
  • Management of inherited and acquired bleeding disorders
• Oversees institutional standards for anticoagulation therapies including warfarin, unfractionated heparin, enoxaparin, direct oral anticoagulants (DOACs), and other parenteral anticoagulants.
• Provides operational and clinical oversight for blood factor and hemostatic therapies, including:
  • 4-factor PCC
  • Coagulation factor concentrates
  • Recombinant clotting factors
  • Fibrinogen replacement products
  • von Willebrand factor products
  • Other specialized hemostatic and reversal agents
• Serves as the primary pharmacy consultant for complex bleeding events, anticoagulation reversal, coagulation disorders, and blood factor utilization across the inpatient setting.
• Guides appropriate utilization of high-cost and high-risk therapies to optimize patient outcomes, patient safety, regulatory compliance, and stewardship of specialty medications.
• Collaborates with Hematology, Transfusion Medicine, Trauma, Critical Care, Surgery, Cardiology, Neurology, Emergency Medicine, and Perioperative Services to standardize thrombosis and hemostasis practices throughout the organization.
• Provides expertise regarding antithrombotic therapies, including warfarin, heparin, enoxaparin, DOACs, cangrelor, ticagrelor, and other anticoagulant and antiplatelet agents.
• Supports institutional emergency response pathways, anticoagulation stewardship programs, and massive transfusion protocols through recommendations on factor replacement, reversal strategies, and hemostatic therapies.
• Oversees formulary management, medication-use evaluations, quality improvement initiatives, and clinical outcomes related to thrombosis, anticoagulation, blood factors, and hemostatic agents.
• Leads education and training for pharmacists, physicians, nurses, residents, and students on thrombosis, hemostasis, anticoagulation, blood factor therapies, and emerging treatment options.
• Evaluates new evidence, medications, and technologies to advance thrombosis and hemostasis care and support system-wide clinical excellence.
• Other…